Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 39–39 | Cite as

Antineoplastics

Bone marrow aplasia: case report
Case report
  • 57 Downloads

Reference

  1. Cerichione C, et al. High-dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed hodgkin lymphoma. Blood 130 (Suppl. 1): 2802, Dec 2017 [abstract] - ItalyGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations